Treating acne with oral contraceptives: use of lower doses
Authors:
- Johannes HuberJHJohannes Huber
- Katharina WalchKWKatharina Walch
- 1 January 2006
- journal article
- review article
- Published by Elsevier in Contraception
- Vol. 73 (1) , 23-29
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Clinical Evidence of the Endocrinological Influence of a Triphasic Oral Contraceptive Containing Norgestimate and Ethinyl Estradiol in Treating Women with Acne vulgarisDermatology, 2003
- A randomized, controlled trial of a low-dose contraceptive containing 20 μg of ethinyl estradiol and 100 μg of levonorgestrel for acne treatmentFertility and Sterility, 2001
- Use of a low-dose oral contraceptive containing norethindrone acetate and ethinyl estradiol in the treatment of moderate acne vulgarisClinical Journal of Woman's Health, 2001
- A large observational clinical evaluation of a desogestrel-containing combiphasic oral contraceptive in GermanyThe European Journal of Contraception & Reproductive Health Care, 2001
- Comparison of the effect on acne with a combiphasic desogestrel-containing oral contraceptive and a preparation containing cyproterone acetateThe European Journal of Contraception & Reproductive Health Care, 2001
- Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: A randomized, placebo-controlled trialObstetrics & Gynecology, 1997
- Selectivity and minimal androgenicity of norgestimate in monophasic and triphasic oral contraceptivesActa Obstetricia et Gynecologica Scandinavica, 1992
- AN OPEN STUDY OF TRIPHASIL AND DIANE 50 IN THE TREATMENT OF ACNEAustralasian Journal of Dermatology, 1991
- Anti-androgen treatment in women with acne: a controlled trialBritish Journal of Dermatology, 1986
- Cyproterone Acetate Versus Levonorgestrel Combined with Ethinyl Estradiol in the Treatment of Acne: Results of a multicenter study*Acta Obstetricia et Gynecologica Scandinavica, 1986